1- Avina-Zubieta J.A et coll. Risk of Cardiovascular Mortality in Patients With
Rheumatoid Arthritis : A Meta-Analysis of Observational Studies. Arthritis & Rheumatism (Arthritis Care & Research) Vol. 59, No. 12, 2008, pp 1690–1697
2- Société Française d'Athérosclérose - Le risque cardio-vasculaire
3- Conroy RM et coll. SCORE project group. Estimation of ten-year of fatal cardiovascular disease in Europe : The SCORE project. Eur Heart J 2003;24(11):987-1003.
4- Goodson NJ et coll. The cardiovascular manifestationsof rheumatic diseases. Curr Opin Rheumatol 2006;18:135–40.
5- Bartoloni E et coll. How early is the atherosclerotic risk in rheumatoid arthritis ? Autoimmun Rev 2010, 9 :701–707.
6- Gabriel SE, et coll. Survival in rheumatoid arthritis : a population-based analysis of trends over 40 years. Arthritis Rheum 2003, 48 :54–58
7- Peters MJ etcoll. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010 69 :325–331.
8- Toms TE et coll. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk : evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis (2010) 69 :683–688
9- HAS 2008 Polyarthrite rhumatoïde évolutive grave. Voir le PDF
10- Soubrier M et coll. Le rhumatologue doit-il prescrire des statines ? Revue du rhumatisme 77 (2010) 115–117
11- Soubrier M et coll. Indications for lowering LDL-c in rheumatoid arthritis : an unrecognized problem. J Rheumatol 2006;33:1766–9.
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025